JG
EWTX icon

Jain Global’s Edgewise Therapeutics EWTX Stock Holding History

Jain Global’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46M Sell
46,401
-67,455
-59% -$1.95M 0.01% 742
2025
Q4 		$2.83M Buy
+113,856
New +$2.29M 0.01% 529
2025
Q1 		– Sell
-7,850
Closed -$210K – 1156
2024
Q4 		$210K Buy
+7,850
New +$250K 0.01% 634

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jain Global's EWTX Position: Q1 2026 in Review

Jain Global reduced its Edgewise Therapeutics (EWTX) stake by 59% in Q1 2026, selling an estimated $1.95M and leaving 46,401 shares worth $1.46M. The position accounts for 0.01% of the portfolio, ranked #742.

Jain Global first reported a position in EWTX in Q4 2024 and has held it in 3 quarters since. The position peaked at $2.83M in Q4 2025. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Jain Global held 46,401 shares of Edgewise Therapeutics worth $1.46M as of Q1 2026.
  • Jain Global sold 67,455 Edgewise Therapeutics shares in Q1 2026, an estimated $1.95M.
  • Edgewise Therapeutics made up 0.01% of Jain Global's portfolio in Q1 2026, its #742 holding.
  • Jain Global first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Jain Global's Edgewise Therapeutics position peaked at $2.83M in Q4 2025.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.